| Demographic data | No. | % |
| Sex |
|
|
| Male | 55 | 53.4 |
| Female | 48 | 46.6 |
| Age (years) |
|
|
| 20 - 40 | 27 | 26.2 |
| >40 - 60 | 76 | 73.8 |
| Min. - Max. | 24.0 - 60.0 | |
| Mean ± SD. | 46.29 ± 8.49 | |
| Median (IQR) | 47.0 (39.0 - 54.0) | |
| Follow up period (months) | ||
| Min. - Max. | 24.0 - 46.0 | |
| Median | 29.28 | |
| Performance status | No. | % |
| 0 | 73 | 70.9 |
| 1 | 28 | 27.2 |
| 2 | 2 | 1.9 |
| Comorbidities | No. | % |
| No | 63 | 61.2 |
| Yes | 40 | 38.8 |
| DM | 14 | 13.6 |
| HTN | 18 | 17.5 |
| HCV | 6 | 5.8 |
| AF | 2 | 1.9 |
| Smoking |
|
|
| Non-smoker | 68 | 66.0 |
| Smoker | 35 | 34.0 |
| Family history | No. | % |
| Negative | 92 | 89.3 |
| Positive | 11 | 10.7 |
| FAP | 3 | 2.9 |
| Colon cancer | 8 | 7.8 |
| Site | No. | % |
| Right side | 45 | 43.7 |
| left side | 58 | 56.3 |
| Presentation | No. | % |
| Intestinal obstruction | 20 | 19.4 |
| Perforation | 10 | 9.7 |
| FBPR | 20 | 19.4 |
| Alternation of bowel habits | 16 | 15.5 |
| Abdominal pain | 23 | 22.3 |
| Constipation | 8 | 7.8 |
| Chronic anemia | 6 | 5.8 |
| Pathology | No. | % |
| Non mucinous | 50 | 48.5 |
| Mucinous | 29 | 28.2 |
| Signet ring ca | 24 | 23.3 |
| LN dissected | No. | % |
| <12 | 15 | 14.6 |
| ≥12 | 88 | 85.4 |
| Min. - Max. | 4.0 - 30.0 | |
| Mean ± SD. | 16.66 ± 6.10 | |
| Median (IQR) | 15.0 (12.0 - 20.0) | |
| TNM staging | No. | % |
| T stage |
|
|
| T2 | 13 | 12.6 |
| T3 | 65 | 63.1 |
| T4 | 25 | 24.3 |
| N stage |
|
|
| N0 | 43 | 41.7 |
| N1 | 36 | 35.0 |
| N2 | 24 | 23.3 |
| M stage |
|
|
| M0 | 103 | 100.0 |
| Stage |
|
|
| II | 43 | 41.7 |
| III | 60 | 58.3 |
| Grade |
|
|
| I | 14 | 13.6 |
| II | 76 | 73.8 |
| III | 13 | 12.6 |
| Tumor marker | No | % |
| Normal | 19 | 18.4 |
| Elevated | 79 | 76.7 |
| Not assessed | 5 | 4.9 |
| Postoperative assessment | No. | % |
| Free | 103 | 100 |